Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Dermira Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Dermira Inc, Medical Devices Deals, 2012 to YTD 2018 10
Dermira Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Dermira Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Dermira Raises USD0.5 Million in Venture Financing 13
Dermira Raises USD1.5 Million in Venture Financing 14
Dermira Raises USD51 Million In Series C Venture Financing 15
Dermira Raises US$35 Million In Series B Financing 17
Dermira Raises USD25 Million in Venture Financing 19
Dermira Raises US$34 Million In Venture Financing 20
Partnerships 21
ImaBiotech Enters into Agreement with Dermira 21
Licensing Agreements 22
Dermira Enters into Licensing Agreement with F. Hoffmann-La Roche and Genentech for Lebrikizumab 22
Maruho Enters into Licensing Agreement with Dermira for DRM04 24
Dermira Enters into Option Agreement with Takeda Pharma 25
Dermira Enters Into Licensing Agreement with Rose U 26
Equity Offering 27
Dermira Raises USD193.8 Million in Public Offering of Shares 27
Dermira Raises USD145 Million in Public Offering of Shares 29
Dermira Raises USD111.3 Million in Public Offering of Shares 31
Dermira Raises USD125 Million in IPO of Shares 33
Dermira Raises USD7.5 Million in Private Placement of Shares 35
Debt Offering 37
Dermira Raises USD287.5 Million in Private Placement of 3% Notes Due 2022 37
Dermira Inc – Key Competitors 38
Dermira Inc – Key Employees 39
Dermira Inc – Locations And Subsidiaries 40
Head Office 40
Recent Developments 41
Financial Announcements 41
Aug 06, 2018: Dermira reports second quarter 2018 financial results and provides corporate update 41
May 03, 2018: Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update 43
Feb 22, 2018: Dermira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 45
Nov 06, 2017: Dermira Reports Third Quarter 2017 Financial Results 47
Aug 07, 2017: Dermira Reports Second Quarter 2017 Financial Results and Provides Corporate Update 48
May 08, 2017: Dermira Reports First Quarter 2017 Financial Results and Provides Corporate Update 49
Feb 28, 2017: Dermira Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 51
Corporate Communications 53
Jan 04, 2017: Dermira Elects Emmanuel Caeymaex to Board of Directors 53
Other Significant Developments 54
Jan 06, 2017: Dermira Provides Corporate Update 54
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
Dermira Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Dermira Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Dermira Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Dermira Inc, Medical Devices Deals, 2012 to YTD 2018 10
Dermira Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Dermira Raises USD0.5 Million in Venture Financing 13
Dermira Raises USD1.5 Million in Venture Financing 14
Dermira Raises USD51 Million In Series C Venture Financing 15
Dermira Raises US$35 Million In Series B Financing 17
Dermira Raises USD25 Million in Venture Financing 19
Dermira Raises US$34 Million In Venture Financing 20
ImaBiotech Enters into Agreement with Dermira 21
Dermira Enters into Licensing Agreement with F. Hoffmann-La Roche and Genentech for Lebrikizumab 22
Maruho Enters into Licensing Agreement with Dermira for DRM04 24
Dermira Enters into Option Agreement with Takeda Pharma 25
Dermira Enters Into Licensing Agreement with Rose U 26
Dermira Raises USD193.8 Million in Public Offering of Shares 27
Dermira Raises USD145 Million in Public Offering of Shares 29
Dermira Raises USD111.3 Million in Public Offering of Shares 31
Dermira Raises USD125 Million in IPO of Shares 33
Dermira Raises USD7.5 Million in Private Placement of Shares 35
Dermira Raises USD287.5 Million in Private Placement of 3% Notes Due 2022 37
Dermira Inc, Key Competitors 38
Dermira Inc, Key Employees 39
List of Figures
Dermira Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Dermira Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Dermira Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Dermira Inc, Medical Devices Deals, 2012 to YTD 2018 10